ND 7001

Drug Profile

ND 7001

Alternative Names: ND-7001

Latest Information Update: 22 Feb 2010

Price : $50

At a glance

  • Originator Evotec AG
  • Class Antidepressants; Anxiolytics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders; Major depressive disorder

Most Recent Events

  • 22 Feb 2010 Discontinued - Phase-I for Anxiety disorders in France (unspecified route)
  • 22 Feb 2010 Discontinued - Phase-I for Depression in France (unspecified route)
  • 29 Mar 2007 Neuro3d has been acquired and merged into Evotec AG
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top